Poly(Beta-Thioester) Polymers and Polymeric Nanoparticles
AssigneeMassachusetts Institute of Technology
InventorsROBERT LANGER, CARLO TRAVERSO, AMEYA KIRTANE, DANIEL REKER, LEWIS SCOTT JONES, HYUNJOON KIM, NETRA RAJESH
Life of this patent
Estimating the term…
Abstract
The disclosure describes poly(β-thioester) polymers and polymeric nanoparticles, pharmaceutical compositions comprising these materials, their use in the treatment of cancer and infectious disease, and machine learning methods for identifying and selecting them.
Claims60
A method of predicting dendritic cell activation by a test polymer comprising:
- identifying the monomeric units of the test polymer and of a training set of polymers, wherein the training set of polymers have known activity in at least one immune activation pathway;
- categorizing the monomeric units into chemically distinct groups;
- generating a set of molecular descriptors of the monomeric units in the training set;
- deriving an algorithm for each chemically distinct group, wherein each algorithm determines the ability of the monomeric units to activate a dendritic cell by configuring the molecular descriptors of the monomeric units with experimentally derived biological data for the polymers in the training set;
- combining the algorithms for each chemically distinct group into a combined algorithm;
- determining a set of molecular descriptors for the test polymer;
- and
- predicting dendritic cell activation of the test polymer using the combined algorithm.
A method of identifying a polymer-based adjuvant for a vaccine comprising:
- selecting one or more test polymers with unknown activity in the activation of dendritic cells;
- determining a set of molecular descriptors for the one or more test polymers;
- by machine, accessing a body of data comprising molecular descriptors and dendritic cell activation data of a set of training polymers, wherein the body of data has been configured to derive an algorithm for determining the ability of a polymer to activate a dendritic cell based on its molecular descriptors;
- applying the set of molecular descriptors for the one or more test polymers to the algorithm;
- identifying a polymer from the one or more test polymers for development into an adjuvant for a vaccine.
A method of preparing an adjuvant for a vaccine comprising:
- by machine, accessing a body of data comprising molecular descriptors and dendritic cell activation data of a set of training polymers, wherein the body of data has been configured to derive an algorithm for predicting the ability of a polymer to activate a dendritic cell based on its molecular descriptors;
- using said algorithm to select a polymer with predicted activity in the activation of dendritic cells;
- synthesizing the polymer;
- precipitating the polymer into nanoparticles.
A high throughput method of synthesizing a nanoparticle library comprising:
- (1) selecting a dithiol and a diacrylate;
- (2) reacting the dithiol and the diacrylate with triethylamine to produce a polymer;
- (3) precipitating the polymer;
- (4) washing the polymer;
- (5) preparing a mixture comprising the polymer and PLGA-PEG in solvent;
- (6) precipitating the mixture to produce nanoparticles;
- (7) repeating steps 2-6 at least one more time, selecting, during each repetition, a different combination of dithiol and diacrylate.
The method of claim 21, further comprising the following steps after step (4):
- (4.1) selecting a monothiol;
- (4.2) reacting the polymer with the monothiol and triethylamine to produce a capped polymer;
- (4.3) precipitating the capped polymer;
- (4.4) washing the capped polymer;
- wherein, the capped polymer is used in place of the polymer in subsequent steps 5-7.
A polymer of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein,
- R1 is
- Y1 is C1-3 alkyl, (C1-6 alkyl)-NHC(═O), C═O, 5 to 10-membered heteroaryl, or absent, wherein heteroaryl is optionally substituted, independently for each occurrence, one, two, or three times with C1-3 alkyl, C1-3 alkoxy, C1-3 haloalkyl, halogen, or 6 to 10-membered aryl;
- Y2 is C1-6 alkyl, 6 to 10-membered aryl, biphenyl, 5 to 10-membered heteroaryl, (CH2CH2O)pCH2CH2, C═N—(C1-6 alkyl)-N═C, O, S, or SO2, wherein the alkyl, aryl, biphenyl, and heteroaryl are optionally substituted, independently for each occurrence, one, two, or three times with C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, (C0-3 alkyl)-OH, NH2, NH(C1-6 alkyl), N(C1-6 alkyl)2, halogen, or carboxylic acid;
- R2 is C1-6 alkyl, 6 to 10-membered aryl, O, or
- Z1 is C1-6 alkyl or 6 to 10-membered aryl;
- Z2 is O, O(C═O)O, or absent;
- Z3 is 6 to 10-membered aryl, 5 to 10-membered heteroaryl, or absent;
- Z4 is C1-6 alkyl, 5 to 15-membered cycloalkyl, 5 to 15-membered heterocyclyl, 6 to 14-membered aryl, 5 to 15-membered heteroaryl, or (C═O)O-(6 to 10-membered aryl)-O(C═O), each of which are optionally substituted, independently for each occurrence, one, two, or three times with C1-3 alkyl, C1-3 haloalkyl, or halogen;
- n is 25-250;
- p is 1, 2, 3, or 4;
- and
- wherein R1, R2, Y1, Y2, Z1, Z2, Z3, and Z4 are each, independently, the same for every occurrence in the polymer.
A polymer of Formula (II):
- or a pharmaceutically acceptable salt thereof, wherein,
- R1 is
- Y1 is C1-3 alkyl, (C1-6 alkyl)-NHC(═O), C═O, 5 to 10-membered heteroaryl, or absent, wherein heteroaryl is optionally substituted, independently for each occurrence, one, two, or three times with C1-3 alkyl, C1-3 alkoxy, C1-3 haloalkyl, halogen, or 6 to 10-membered aryl;
- Y2 is C1-6 alkyl, 6 to 10-membered aryl, biphenyl, 5 to 10-membered heteroaryl, (CH2CH2O)pCH2CH2, C═N—(C1-6 alkyl)-N═C, O, S, or SO2, wherein the alkyl, aryl, biphenyl, and heteroaryl are optionally substituted, independently for each occurrence, one, two, or three times with C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, (C0-3 alkyl)-OH, NH2, NH(C1-6 alkyl), N(C1-6 alkyl)2, halogen, or carboxylic acid;
- R2 is C1-6 alkyl, 6 to 10-membered aryl, O, or
- Z1 is C1-6 alkyl or 6 to 10-membered aryl;
- Z2 is O, O(C═O)O, or absent;
- Z3 is 6 to 10-membered aryl, 5 to 10-membered heteroaryl, or absent;
- Z4 is C1-6 alkyl, 5 to 15-membered cycloalkyl, 5 to 15-membered heterocyclyl, 6 to 14-membered aryl, 5 to 15-membered heteroaryl, or (C═O)O-(6 to 10-membered aryl)-O(C═O), each of which are optionally substituted, independently for each occurrence, one, two, or three times with C1-3 alkyl, C1-3 haloalkyl, or halogen;
- R3 is C1-6 alkyl, C(═O)—C1-6 alkyl, 6 to 10-membered aryl, 5 to 10-membered heteroaryl, (C1-6 alkyl)-(6 to 10-membered aryl), (C1-6 alkyl)-(5 to 10-membered heteroaryl), and 5 to 15-membered heterocyclyl, each of which is optionally substituted, independently for each occurrence, one, two, or three times, independently, with C1-3 alkyl, C1-3 alkoxy, C1-3 haloalkyl, acetamide, carboxylic acid, silyl, hydroxyl, cyano, nitro, and halogen;
- n is 25-250;
- p is 1, 2, 3, or 4;
- and
- wherein R1, R2, R3, Y1, Y2, Z1, Z2, Z3, and Z4 are each, independently, the same for every occurrence in the polymer.
Dependencies are inferred from the claim text.